“Global Antibiotic Drugs market set to grow to $43.8bn by 2022” says Visiongain analyst

18 June 2018
Pharma

Visiongain’ has launched a new pharma report Top 25 Antibiotic Drugs Manufacturers 2018: US, Europe, Japan, Cephalosporins, Penicillins, Fluoroquinolones, Macrolides, Carbapenems, Others

The development of antibacterial resistance has created an opportunity for the drug industry as new anti-infectives are constantly required to target resistant organisms. Currently, a major opportunity lies in the development of drugs required for the treatment of hospital acquired infections and are associated with increased mortality and morbidity. Hence, most of the pharmaceutical companies are recommended to develop combination products to broaden the antibacterial spectrum of activity for combating bacterial resistance.

The lead analyst of the report commented: “Asia-Pacific and RoW are the fastest growing regional markets in the global antibacterial drugs market. Therefore, companies looking to accelerate their overall growth are recommended to invest in these emerging economies and to exploit the untapped growth opportunities available there. Companies are recommended to invest in emerging nations such as India and China, to capitalize on the opportunities available in the form of unmet medical needs, rising disposable incomes of the consumers and increased exposure to improved healthcare facilities.”

Leading companies featured in the report include Pfizer Inc., Merck & Co., Novartis, GSK, Bayer AG, Allergan plc, Shionogi & Co., Ltd., Taisho Pharmaceutical Holdings, Daiichi Sankyo, Sun Pharmaceutical Industries

Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongain.com or call her on +44 (0) 207 336 6100

About visiongain
Visiongain is one of the fastest-growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports cusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.

Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.

Recent News

Visiongain Publishes Healthcare Cold Chain Logistics Market Report 2020-2030

. The growth of this market is majorly driven by increasing sales of temperature sensitive pharmaceutical products, longer life expectancy and rising geriatric population are some of the prominent factors.

16 September 2020

Read

Visiongain Publishes Vaccines Sales Market Report 2020-2030

Visiongain forecasts a continuing growth in global market, submarket and product sales as human vaccines drive pharmaceutical business sales. New key players and technological progress will enter the industry, leading to an increase in the market size of the world market for human vaccines in general.

14 September 2020

Read

Visiongain Publishes Ophthalmic Ultrasound Systems Market Report 2020-2030

The global ophthalmic ultrasound systems market is driven by factors such as the increasing prevalence of ocular disorders and diseases, adoption of novel ophthalmic technologies, rising focus on research & development, and growing health awareness amongst the population.

09 September 2020

Read

Visiongain Publishes Drug Discovery Outsourcing Market Report 2020-2030

The current COVID-19 pandemic is anticipated to have a minor impact on the overall outsourcing business outlook for global drug discovery. Also, significant growth during the COVID-19 pandemic is expected to be seen in the outsourcing of drugs and medicines needed to treat COVID-19 infections.

07 September 2020

Read

Kelloggs
3m
Thales
Shell
TEVA
Lockheed-Martin
Pfizer
Raytheon
Halliburton
Du-Pont
Honeywell
Daimler
BASF
Bayer
BP
BAE-Systems
Unilever